Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
68.69
-1.02 (-1.46%)
At close: Mar 18, 2026, 4:00 PM EDT
68.75
+0.06 (0.09%)
After-hours: Mar 18, 2026, 4:10 PM EDT

Inhibrx Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9992231,8001,0731,7031,243
Market Cap Growth
408.19%-87.61%67.69%-36.96%36.95%-
Enterprise Value
952.8376.791,7301,0051,6471,151
Last Close Price
68.6915.4038.0024.6443.6732.97
PE Ratio
-0.14-1.86-6.81-20.31-10.95
PS Ratio
713.581114.641000.02489.70235.4896.48
PB Ratio
27.041.6741.3818.4932.5116.47
P/TBV Ratio
28.851.7310.2917.0231.6911.04
P/FCF Ratio
--1.13-9.10-9.25-20.97-25.20
P/OCF Ratio
--1.15-9.31-9.31-21.20-25.92
EV/Sales Ratio
680.59383.93961.22458.39227.7689.28
EV/EBITDA Ratio
--0.23-7.94-7.86-21.85-17.32
EV/EBIT Ratio
--0.23-7.89-7.78-21.51-17.06
EV/FCF Ratio
--0.39-8.74-8.66-20.29-23.32
Debt / Equity Ratio
2.840.054.783.541.440.48
Debt / EBITDA Ratio
-0.71-0.02-0.96-1.62-1.02-0.56
Debt / FCF Ratio
-0.74-0.04-1.06-1.79-0.95-0.76
Net Debt / Equity Ratio
-1.25-1.08-1.56-1.15-1.03-1.21
Net Debt / EBITDA Ratio
0.310.440.310.520.721.37
Net Debt / FCF Ratio
0.320.730.340.580.671.85
Asset Turnover
0.010.000.010.010.050.15
Quick Ratio
4.283.764.959.945.894.12
Current Ratio
4.493.945.2510.176.204.21
Return on Equity (ROE)
-182.01%1905.92%-475.31%-263.00%-127.91%841.34%
Return on Assets (ROA)
-85.99%-135.66%-73.22%-58.51%-52.05%-79.24%
Return on Invested Capital (ROIC)
1516.29%1880.87%1335.92%-26137.58%6925.90%2847.61%
Return on Capital Employed (ROCE)
-109.43%-169.27%-85.15%-65.99%-63.71%-114.06%
Earnings Yield
-15.52%731.30%-53.89%-14.69%-4.92%-9.13%
FCF Yield
-14.36%-88.37%-10.99%-10.81%-4.77%-3.97%
Buyback Yield / Dilution
-0.07%-32.15%-11.24%-12.12%-2.59%-11.01%
Updated Nov 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q